Efficacy and Safety of Denosumab Compared With Risedronate in Individuals Taking Glucocorticoids
Public ClinicalTrials.gov record NCT01575873. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-blind, Active-controlled Study to Evaluate the Efficacy and Safety of Denosumab Compared With Risedronate in Glucocorticoid-treated Individuals
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a 2-year study to evaluate the effect of denosumab versus risedronate in adults with glucocorticoid-induced osteoporosis.
Study identification
- NCT ID
- NCT01575873
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 795 participants
Conditions and interventions
Interventions
- Denosumab Drug
- Placebo for risendronate Drug
- Risendronate Drug
- Placebo for denosumab Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 28, 2012 (Actual)
- Primary completion
- Jun 21, 2016 (Actual)
- Completion
- Jun 29, 2017 (Actual)
- Last update posted
- Jul 27, 2018
2012 – 2017
United States locations
- U.S. sites
- 18
- U.S. states
- 14
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Birmingham | Alabama | 35294 | — |
| Research Site | Sacramento | California | 95817 | — |
| Research Site | Lakewood | Colorado | 80227 | — |
| Research Site | Pembroke Pines | Florida | 33029 | — |
| Research Site | Gainesville | Georgia | 30501 | — |
| Research Site | Chicago | Illinois | 60611 | — |
| Research Site | Evanston | Illinois | 60201 | — |
| Research Site | Indianapolis | Indiana | 46202 | — |
| Research Site | Bethesda | Maryland | 20817 | — |
| Research Site | Cumberland | Maryland | 21502 | — |
| Research Site | Boston | Massachusetts | 02118 | — |
| Research Site | Detroit | Michigan | 48236 | — |
| Research Site | Fargo | North Dakota | 58103 | — |
| Research Site | Fargo | North Dakota | 58104 | — |
| Research Site | Mayfield | Ohio | 44143 | — |
| Research Site | Duncansville | Pennsylvania | 16635 | — |
| Research Site | Wyomissing | Pennsylvania | 19610 | — |
| Research Site | Beckley | West Virginia | 25801 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 81 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01575873, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 27, 2018 · Synced Oct 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01575873 live on ClinicalTrials.gov.